コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rs depending on what dNTP is bound in the A2 allosteric site.
2 bstrate ATP, indicating that they act via an allosteric site.
3 Ras.GDP cannot properly activate Sos at the allosteric site.
4 ugh interaction with a previously unrevealed allosteric site.
5 opriate model receptor for investigating the allosteric site.
6 ds designed to bind irreversibly to the CB1R allosteric site.
7 (176), a trigger between the active site and allosteric site.
8 ed by the binding of an effector to a distal allosteric site.
9 ected by different dNTP ligands bound in the allosteric site.
10 with two orthosteric binding modes and to an allosteric site.
11 ed that they most likely used an overlapping allosteric site.
12 refined to recognize lorazepam in a putative allosteric site.
13 ut not ppGpp-positively regulates SAS1 at an allosteric site.
14 AChR by loop II without penetration into the allosteric site.
15 compounds acting at a common, transmembrane allosteric site.
16 tly with the orthosteric site and part of an allosteric site.
17 he active site or occupation of a regulatory allosteric site.
18 active site of PBP2a within the core of the allosteric site.
19 t screening hit that binds in a nonconserved allosteric site.
20 crease in NADP-ME2 activity by binding to an allosteric site.
21 lecules activate relaxin receptor through an allosteric site.
22 ibition potency supporting recognition of an allosteric site.
23 site and suggests the presence of a second, allosteric site.
24 that the inhibitor unexpectedly binds to an allosteric site.
25 ition in switch II upon ligand binding at an allosteric site.
26 etects the binding of ligands to this unique allosteric site.
27 I1, a BRAF inhibitor that fully uncovers the allosteric site.
28 d results from binding of this vitamer at an allosteric site.
29 ligand that binds specifically to the mGluR5 allosteric site.
30 mOctR, and alpha2C-adrenergic receptor at an allosteric site.
31 eatures regulate access of AZ10606120 to the allosteric site.
32 , an HspQ binding site and an HspQ-modulated allosteric site.
33 e that these inhibitors bind to the proposed allosteric site.
34 red by an inability to precisely control the allosteric site.
35 e for high-throughput searches for candidate allosteric sites.
36 control of protein function by modulation of allosteric sites.
37 vation and the absence of broadly applicable allosteric sites.
38 state of the protein when they bind to their allosteric sites.
39 dulate nAChR function by binding to distinct allosteric sites.
40 involving binding to both the catalytic and allosteric sites.
41 hich successfully identifies orthosteric and allosteric sites.
42 r Cys-loop receptors, by binding to distinct allosteric sites.
43 c activity by dGTP binding at four identical allosteric sites.
44 effective inhibitors and help identify novel allosteric sites.
45 r energetic coupling with Phe binding in the allosteric sites.
46 odulation by ligands acting through numerous allosteric sites.
47 he highly conserved ACh-binding site, termed allosteric sites.
48 the adenine/guanine mononucleotides for the allosteric sites.
49 r ligand binding pockets and orthosteric and allosteric sites.
50 hosphorylase activity or the location of its allosteric sites.
51 nactive kinase conformations, or act through allosteric sites.
52 all molecules that are able to interact with allosteric sites.
53 ion of cooperativity between orthosteric and allosteric sites.
54 D1 is activated by binding of GTP or dGTP at allosteric site 1 and a dNTP of any type at allosteric s
56 Moreover, ATP and dATP bind at an additional allosteric site 40 A away from loop 2 and thereby drive
57 ic EF1143 contains four additional secondary allosteric sites adjacent to the previously identified d
58 d potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while re
60 rovides new insights into the mechanisms and allosteric sites [alpha(-)-interface containing] by whic
62 cribed to stem from sole interaction with an allosteric site, although the evidence for such a mechan
63 unexpected presence of a previously unknown allosteric site and an unusual dodecameric structure for
64 sight into dNTP promiscuity at the secondary allosteric site and how enzymatic activity is modulated.
65 f a FRET-based sensor of conformation at the allosteric site and in pharmacological assays involving
67 losteric transition, we vary the size of the allosteric site and its interactions to construct a seri
68 ropose that Plasmodium Kinesin-5 shares this allosteric site and likewise can be targeted to uncover
69 of structural information regarding the A1AR allosteric site and mechanisms governing cooperativity w
70 not exhibit sodium ion binding to the D2.50 allosteric site and samples a significantly larger confo
71 ctively inhibit mutant IDH1 by binding to an allosteric site and that inhibition is competitive with
72 3) pharmacological compounds targeting this allosteric site and utilizing this mode of inhibition.
75 at there are many as yet undiscovered hidden allosteric sites and suggests our methodology can identi
77 tanding of the biological relevance of these allosteric sites and the way forward to design more-pote
78 and FTSite are useful tools for identifying allosteric sites and to aid in the design of such compou
79 efined orthosteric binding site and possible allosteric sites and to analyze the importance of the li
81 concomitant association with orthosteric and allosteric sites) and that the compound displays biased
83 Affinities of isoflurane and propofol to the allosteric site are also calculated, and shown to be 3 m
84 hibition is cooperative, indicating that the allosteric sites are not independent despite being locat
85 nowledge of the target site, but most hidden allosteric sites are only discovered when a small molecu
86 The results identify the location of the allosteric site as the interface of the regulatory domai
87 that incorporates competition for active and allosteric sites, as well as functional sequestration of
88 us, the current study identifies novel c-Src allosteric sites associated with imatinib binding and ki
89 e D3R(Dopa) model are predicted to occupy an allosteric site at the extracellular extension of the po
93 structures revealed 3 binds to an unexpected allosteric site between the C-terminal and the N-termina
94 om the orthosteric site up toward a putative allosteric site bordered by TM2, TM3, and TM7, thus cons
95 he modulator's high binding affinity for the allosteric site but not for generating allostery on the
96 ctive protein kinase inhibitors by targeting allosteric sites, but these sites often involve protein-
98 lactam antibiotics, wherein occupancy at the allosteric site by one facilitates occupancy by a second
100 vity via non-competitive antagonism from two allosteric sites, by channeling the inhibition towards t
101 by which glucose 6-phosphate binding at the allosteric site communicates with the PykA active site.
102 y result in a higher affinity of dTTP to the allosteric site conferring its inhibitory activity.
104 In addition, we discuss how targeting of allosteric sites could provide new opportunities to inhi
105 l structure shows that the compound binds an allosteric site created by the displacement of the regul
107 with PBP2a-each with the beta-lactam in the allosteric site-defined (with preceding PBP2a structures
111 Unexpectedly, these drugs all bind to an allosteric site distinct from the ATP-binding pocket in
112 two inhibitor molecules interact within the allosteric site, driving significant conformational chan
114 m in adult liver, harbors two noninteracting allosteric sites, each of which binds a different molecu
115 gest that tiotropium binds transiently to an allosteric site en route to the binding pocket of both r
116 ly inhibit the KRAS isoform by binding to an allosteric site encompassing the region around KRAS-spec
121 noceptor (alpha(1B)-AR) to help identify the allosteric site for rho-conopeptide TIA, an inverse agon
126 ol of protein allostery and design of unique allosteric sites for potential enzyme inhibitors with re
129 Rather, we propose that a transient propofol allosteric site forms when the motor head binds to the m
130 s of decoupling the identification of hidden allosteric sites from the discovery of drugs that bind t
132 stinct from the orthosteric sites, so-called allosteric sites, has heralded novel approaches and mode
134 -domain shows that they bind to the I-domain allosteric site (IDAS), the binding site of other allost
137 ng mode involving residues within TM10 in an allosteric site in BGT1 that corresponds to the alloster
138 ransfer (CEST) interactions with the primary allosteric site in bla give rise to a unique saturation
139 of a cytohesin-3 construct encompassing the allosteric site in complex with the head group of phosph
141 1,013 compounds for possible binding to the allosteric site in farnesyl diphosphate synthase (FPPS).
144 he active conformation, whereas targeting an allosteric site in the dimer interface selects an inacti
145 ings show a novel mode of agonism through an allosteric site in the extracellular domain of alpha7 nA
146 rlaps with the previously described "common" allosteric site in the extracellular vestibule of the M1
147 complex show that (S)-CPP binds to a unique allosteric site in the N-terminal domain, triggering hel
149 rotein backbone is used to identify putative allosteric sites in a series of antibody fragments.
150 ion of these methods reveals multiple hidden allosteric sites in an important antibiotic target--TEM-
152 es a simple method for identification of new allosteric sites in PTP, and given the basis of this met
153 However, it has been a challenge to identify allosteric sites in target proteins where insertion of r
154 is approach, we apply it to discover cryptic allosteric sites in two different beta-lactamase enzymes
155 some GPCRs possess more than one targetable allosteric site, in addition to a growing list of putati
156 this loop motion to effector binding at the allosteric site, in order to identify the signaling path
157 yme toward 2-AG, whereas 2-AG binding at the allosteric site increases COX-2's efficiency toward AA.
158 stent with Na(+) binding to an extracellular allosteric site, independent of the ion transport sites,
159 e example of this, we have introduced distal allosteric sites into molecular beacons, which are optic
160 f arsenic-bound p53 mutants reveal a cryptic allosteric site involving three arsenic-coordinating cys
161 et Mtb-fumarase by binding to a nonconserved allosteric site is a major advancement, providing furthe
163 y inhibit RNA synthesis, suggesting that the allosteric site is not always available during RNA synth
166 ystal structures, a possible location of the allosteric site is within a cleft between the alpha- and
167 straightforward approach to identify hidden allosteric sites is demonstrated in protein tyrosine pho
169 mimics of the acyl-D-Ala-D-Ala moiety at the allosteric site, lead to a conformational change, across
170 eptors suggest that TCN-201 binds to a novel allosteric site located at the dimer interface between t
172 We extended previous observations that an allosteric site located in the vestibule of the receptor
174 involved variation at positions primarily at allosteric sites located outside of binding pockets, whe
175 these observations, we propose that cryptic allosteric sites may be even more ubiquitous than previo
176 ric sites, the force of anaesthetics through allosteric sites may not propagate to the neighbouring s
177 also influence the activity by binding to an allosteric site, most likely the pseudosymmetric site lo
178 ggable pocket that is the most intracellular allosteric site observed in class A G-protein-coupled re
180 ompetitive interaction of AA and 2-AG at the allosteric site of COX-2 might result in differential re
181 a revealed that binding of AA or 2-AG at the allosteric site of COX-2 results in a decreased catalyti
182 ity in the dimer interface could serve as an allosteric site of hTS to regulate the conformational sw
184 the glutamatergic neurotransmission (glycine allosteric site of NMDA receptors or alpha-amino-3-hydro
185 ocument that this mimicry exists also at the allosteric site of PBP2a of methicillin-resistant Staphy
186 ability of the quinazolinones to bind to the allosteric site of penicillin-binding protein (PBP)2a, r
187 ovalent metal ions indirectly influences the allosteric site of Pfk-2 by increasing its affinity for
190 drogens of human androgen receptor (AR), the allosteric site of the AR binding function 3 (BF3) was i
191 tion mutagenesis in a single position of the allosteric site of the dimer interface, and we show that
192 ts as an allosteric ligand that binds at the allosteric site of the enzyme's interfacial surface, shi
193 (11)C-ABP688, a PET ligand that binds to an allosteric site of the metabotropic glutamate 5 receptor
194 o affinity of (11)C-ABP688 for binding to an allosteric site of the metabotropic glutamate 5 receptor
199 t form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new
202 es, we find that Org 27569 binds to a unique allosteric site on CB1 and show that it can act alone (w
204 ligands and describes another example of an allosteric site on G-protein-coupled receptors that can
205 work has extensively characterized a common allosteric site on mGlu5, termed the MPEP (2-Methyl-6-(p
207 the same GarA FHA-binding pocket targets an allosteric site on nonphosphorylated KGD, where a key el
208 iously described the identification of a new allosteric site on the catalytic alpha-subunit, along wi
209 ecific drug-protein interactions validate an allosteric site on the channel periphery and its relevan
210 artial inverse agonist at the benzodiazepine allosteric site on the gamma-aminobutyric acid (GABA)(A)
211 s, EGFR and HER2, is achieved by engaging an allosteric site on the HER3 kinase domain, but this site
214 proach to targeting a functionally conserved allosteric site on the protein kinase PDK1 called the PD
217 induced by ligand binding to orthosteric or allosteric sites on a G protein-coupled receptor (GPCR)
221 took advantage of the many tools for probing allosteric sites on mGlu(5) to validate an operational m
222 hanced receptor gating by rapidly binding to allosteric sites on open channels, initiating a rate-lim
225 nslational modifications or metal binding to allosteric sites on the enzyme, which stabilize inactive
230 Two other RNA molecules bind DNMT3A at an allosteric site outside the catalytic domain, causing no
232 gonist MK-0893, which is found to bind to an allosteric site outside the seven transmembrane (7TM) he
233 ion of these residues is consistent with two allosteric sites per dimer, with each site containing re
234 f rhodopsin-like GPCRs suggest that specific allosteric sites play a pivotal role in activating struc
235 s with mGlu5 modulators have relied on mGlu5 allosteric site positron emission tomography (PET) radio
236 et regions in LF did not, suggesting that an allosteric site preferentially recognizes alpha-helical
238 g (25 angstrom) of single-stranded DNA in an allosteric site primes the active site by conformational
240 by the effector, modeled by the size of the allosteric site, provides an order parameter for alloste
241 cy may result from binding of propofol to an allosteric site recently identified by X-ray crystallogr
244 simulations wherein substrate binding to an allosteric site remote from the active site opens up cha
245 ee-dimensional NMR solution structure of the allosteric site revealed an alpha-helix with a loop conn
246 ary, a novel inhibitor scaffold targeting an allosteric site shared between flaviviral NS2B/NS3 prote
251 were more significantly enriched at protein allosteric sites than tolerated mutations, suggesting a
252 Here, we describe the discovery of a SULT1A3 allosteric site that can be used to inhibit the enzyme.
253 in a protein involves effector binding at an allosteric site that changes the structure and/or dynami
255 GTP relieves autoinhibition by binding to an allosteric site that includes the autoinhibitory element
256 esent a cryptic drug-binding pocket near the allosteric site that may be amenable to targeting with s
257 (-) binding to a high-affinity non-transport allosteric site that prevents Na(+) from binding to one
258 thway connecting the active site to the main allosteric site that remains in the substrate-bound form
259 Instead, omecamtiv mecarbil binds to an allosteric site that stabilizes the lever arm in a prime
260 xperiments, the human Kinesin-5 has multiple allosteric sites that are "druggable." One site in parti
262 of BCR-ABL have led to the identification of allosteric sites that are distant from the ATP-binding p
263 erefore, have shifted to the exploitation of allosteric sites that can regulate phosphatase activity
264 t propofol is not binding at the ATP site or allosteric sites that modulate microtubule-activated ATP
265 hods were also able to find partially hidden allosteric sites that were not fully formed in X-ray str
266 r, DF2593A, guided by the hypothesis that an allosteric site, the "minor pocket," previously characte
267 This process is tightly regulated via two allosteric sites, the specificity site (s-site) and the
269 anism by binding to a previously undescribed allosteric site: the interface of the two cAMP binding d
270 is class of inhibitors acts by binding to an allosteric site; the novel binding site is proposed in s
271 re capable of forming a complex with the SOS allosteric site, thus aberrantly promoting SOS autoactiv
272 n that couples effector ligand binding at an allosteric site to a structural and/or dynamic change at
273 ta2 loop, and beta4 loop and functions as an allosteric site to enhance the efficiency of activation
274 rotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) allosteric site to potentiate endogenous 5-HT tone may p
278 In particular, the transmission from the allosteric site to the signaling surface of the receiver
279 3A binds H3 tails and p53 or TDG at distinct allosteric sites to form DNMT3A-H3 tail-p53 or -TDG mult
280 strate the utility of purposefully targeting allosteric sites to obtain mutant-selective inhibitors.
281 samples across 33 cancer types into protein allosteric sites to prioritize the mutated allosteric pr
282 y nucleic acid binding affinity; and surface allosteric sites, to control recruitment of additional p
283 rtant insights into the structural bases for allosteric site-to-active site communication and for bet
286 mGluR5 receptor binding specifically to an allosteric site was observed by using positron emission
288 connections between the active site and the allosteric site were indicated by equilibrium binding ex
290 increase in affinity for the peptide in the allosteric site when KIX is prebound by a complementary
291 of the cube also provided a distinct second allosteric site, where the binding of tetraphenylborate
292 opentenyl diphosphate, IPP) site, not to the allosteric site, whereas zoledronate bound via Mg(2+) to
293 is model was validated by mutagenesis of the allosteric site, which led to constitutively active SARM
294 tions allows us to identify potential hidden allosteric sites, which we then test via thiol labeling
296 however, has been on modes of targeting GPCR allosteric sites with chemical probes due to the potenti
297 dies indicate that dGTP binding to the first allosteric site, with nanomolar affinity, is a prerequis
298 y of discovery programs focused on targeting allosteric sites, with allosteric ligands now available
299 83% and 88% of such experimentally confirmed allosteric sites within the three strongest sites found.